Our group has prior investigated the role of TRAIL in pathological conditions such as acute myocardial infarction, diabetes and hypercholesterolemia, and indicated that circulating levels of TRAIL inversely correlate with all-causes and cardiovascular mortality [4–14]. This evidence concerns the gene TNFSF10 and Hypercholesterolemia.